These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1174160)

  • 21. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between saralsin and converting enzyme inhibitor in hypertensive disease.
    Case DB; Wallace JM; Laragh JH
    Kidney Int Suppl; 1979 Mar; (9):S107-114. PubMed ID: 225598
    [No Abstract]   [Full Text] [Related]  

  • 23. [Diagnostic and therapeutic significance of antagonists of the renin-angiotensin system (author's transl)].
    Stumpe KO; Overlack A; Krück F
    Herz; 1978 Oct; 3(5):305-12. PubMed ID: 721057
    [No Abstract]   [Full Text] [Related]  

  • 24. Angiotensin blockade: its clinical significance.
    Streeten DH; Anderson GH; Dalakos TH
    Am J Med; 1976 May; 60(6):817-24. PubMed ID: 1020761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of saralasin on 20 hypertensive patients (author's transl)].
    Plaza de los Reyes M; Passalacqua W; Plaza de los Reyes X; Pla C; Campino C
    Rev Med Chil; 1980 Feb; 108(2):115-20. PubMed ID: 7017869
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of biological effects of three angiotensin II antagonists in sodium depleted hypertensive patients.
    Ogihara T; Nakamaru M; Higaki J; Hata T; Kumagai A; Kumahara Y
    Med J Osaka Univ; 1983 Sep; 34(1-2):21-5. PubMed ID: 6366501
    [No Abstract]   [Full Text] [Related]  

  • 27. The renin/angiotensin system.
    Lee MR
    Br J Clin Pharmacol; 1981 Nov; 12(5):605-12. PubMed ID: 6174135
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparison of effects of two angiotensin II antagonists on blood pressure, heart rate, plasma renin activity, and plasma aldosterone concentration in the same hypertensive patients].
    Higuma K; Fujishima S; Shionoiri H; Tochikubo O; Uneda S; Fujiki Y; Kaneko Y
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):425-35. PubMed ID: 6381833
    [No Abstract]   [Full Text] [Related]  

  • 29. Converting enzyme, angiotensin II and hypertensive disease.
    Soffer RL; Case DB
    Am J Med; 1978 Jan; 64(1):147-160. PubMed ID: 203191
    [No Abstract]   [Full Text] [Related]  

  • 30. Angiotensin inhibitors for hypertension.
    Gavras H; Gavras I; Brunner HR
    Compr Ther; 1980 May; 6(5):14-8. PubMed ID: 6155240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiologic studies with saralasin in animals.
    Gavras H; Gavras I; Brunner HR; Liang CS
    Kidney Int Suppl; 1979 Mar; (9):S20-8. PubMed ID: 384069
    [No Abstract]   [Full Text] [Related]  

  • 32. [Renin and sodium in blood pressure regulation].
    Brunner HR; Gavras H
    Schweiz Med Wochenschr; 1974 Oct; 104(40):1401-11. PubMed ID: 4376263
    [No Abstract]   [Full Text] [Related]  

  • 33. Renin lowers blood-pressure.
    Gordon DB
    Lancet; 1978 Nov; 2(8097):970-2. PubMed ID: 81992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrarenal effects of the renin-angiotensin system.
    Ploth DW; Navar LG
    Fed Proc; 1979 Aug; 38(9):2280-5. PubMed ID: 456614
    [No Abstract]   [Full Text] [Related]  

  • 35. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Lancet; 1975 Oct; 2(7939):784-7. PubMed ID: 78152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
    Pettinger WA; Mitchell HC
    N Engl J Med; 1975 Jun; 292(23):1214-7. PubMed ID: 236513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of saralasin in hypertensive patients on chronic hemodialysis.
    Lifschitz MD; Kirschenbaum MA; Rosenblatt SG; Gibney R
    Ann Intern Med; 1978 Jan; 88(1):23-7. PubMed ID: 619754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients.
    Fagard R; Amery A; Lijnen P; Reybrouck T
    Eur J Clin Pharmacol; 1977 Aug; 12(1):1-5. PubMed ID: 902672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lowering of hypertension by central saralasin in the absence of plasma renin.
    Phillips MI; Mann JF; Haebara H; Hoffman WE; Dietz R; Schelling P; Ganten D
    Nature; 1977 Dec; 270(5636):445-7. PubMed ID: 593364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.